Press Releases May 13, 2026 04:15 PM

KRONOS WORLDWIDE, INC. ANNOUNCES QUARTERLY DIVIDEND AND RESULTS OF ANNUAL STOCKHOLDER MEETING

Kronos Worldwide Declares Quarterly Dividend and Reports Stockholder Meeting Results

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
KRO

Kronos Worldwide, Inc. announced a quarterly dividend of $0.05 per share payable June 18, 2026. At the annual stockholder meeting, all nominated directors were elected for one-year terms and a nonbinding advisory vote approved executive compensation.

KRONOS WORLDWIDE, INC. ANNOUNCES QUARTERLY DIVIDEND AND RESULTS OF ANNUAL STOCKHOLDER MEETING
KRO
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Declared a quarterly dividend of $0.05 per share payable on June 18, 2026.
  • All nominated directors were re-elected for one-year terms at the 2026 annual meeting.
  • Stockholders gave nonbinding advisory approval of the company’s executive compensation plan.
  • The company is a major international producer of titanium dioxide products impacting the chemical and materials sectors.

DALLAS, TEXAS, May 13, 2026 (GLOBE NEWSWIRE) -- Kronos Worldwide, Inc. (NYSE:  KRO) announced that its board of directors has declared a regular quarterly dividend of five cents ($0.05) per share on its common stock, payable on June 18, 2026 to stockholders of record at the close of business on June 4, 2026.

Kronos Worldwide also announced that at its 2026 annual stockholder meeting held today its stockholders had:

  • elected each of Brian W. Christian, Loretta J. Feehan, John E. Harper, Kevin B. Kramer, Meredith W. Mendes, Cecil H. Moore, Jr., Michael S. Simmons, and R. Gerald Turner as a director for a one-year term; and
  • adopted a resolution that approved, on a nonbinding advisory basis, the compensation of its named executive officers as disclosed in the proxy statement for the 2026 annual stockholder meeting.

Kronos Worldwide, Inc. is a major international producer of titanium dioxide products.

* * * * *

Investor Relations Contact

Bryan A. Hanley
Senior Vice President and Treasurer
Tel. 972-233-1700


Risks

  • Dividend payments depend on company profitability and cash flow, which could vary with market conditions.
  • Executive compensation approval is nonbinding and could lead to future shareholder concerns if performance falters.
  • Market demand for titanium dioxide and related products is subject to economic cycles impacting manufacturing and construction sectors.

More from Press Releases

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026 Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) Jun 14, 2026 Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026